Objectives: (1) To assess the incidence of melanoma in a cohort of patients with dysplastic melanocytic naevi (DMN) and the relationships between incident melanomas and preexisting naevi and between melanoma risk and numbers of DMN. (2) To examine the role of the patient versus the physician in detecting melanoma and the relative value of surveillance versus prophylactic excision.Design: Prospective cohort study.Patients and setting: Two hundred and seventy-eight adults, each with five or more DMN, were followed up for a mean period of 42 months in a private dermatology practice. DMN were clinically diagnosed.Results: Twenty new melanomas were detected in 16 patients, corresponding to an age-adjusted incidence of 1835/100 000 person-years, ...
Introduction Melanoma is Australia's fourth most common cancer. Early detection is fundamental in ma...
The risk of hereditary cutaneous malignant melanoma was evaluated in 401 members of 14 families with...
INTRODUCTION: The evidence-based national clinical practice guidelines for the management of cutaneo...
A historical cohort of 153 patients with dysplastic nevi was studied for the development of melanoma...
BACKGROUND/OBJECTIVES: Melanoma may develop de novo or naevus associated (NAM). The exact prevalence...
Importance: A previous single-center study observed fewer excisions, lower health care costs, thinne...
The current standard of care for high-risk melanoma patients is a two-step process using Total Body ...
Background. For more than 25 years families with an increased susceptibility to melanoma have been u...
BACKGROUND/OBJECTIVES: To describe the method of diagnosis, clinical management and adherence to cli...
We evaluated the risk of developing melanoma over time in members of 23 melanoma-prone families. All...
The current standard of care for high-risk melanoma patients is a two-step process using Total Body ...
BACKGROUND: The presence of multiple melanocytic naevi is a strong risk factor for melanoma. Use of ...
Many countries have seen a dramatic increase in the reported incidence of cutaneous melanoma in rece...
Background and Objectives: Naevi may change in size, shape and colour due to multiple inherent and e...
Clinical guidelines recommend that people at high risk of melanoma receive regular surveillance, as ...
Introduction Melanoma is Australia's fourth most common cancer. Early detection is fundamental in ma...
The risk of hereditary cutaneous malignant melanoma was evaluated in 401 members of 14 families with...
INTRODUCTION: The evidence-based national clinical practice guidelines for the management of cutaneo...
A historical cohort of 153 patients with dysplastic nevi was studied for the development of melanoma...
BACKGROUND/OBJECTIVES: Melanoma may develop de novo or naevus associated (NAM). The exact prevalence...
Importance: A previous single-center study observed fewer excisions, lower health care costs, thinne...
The current standard of care for high-risk melanoma patients is a two-step process using Total Body ...
Background. For more than 25 years families with an increased susceptibility to melanoma have been u...
BACKGROUND/OBJECTIVES: To describe the method of diagnosis, clinical management and adherence to cli...
We evaluated the risk of developing melanoma over time in members of 23 melanoma-prone families. All...
The current standard of care for high-risk melanoma patients is a two-step process using Total Body ...
BACKGROUND: The presence of multiple melanocytic naevi is a strong risk factor for melanoma. Use of ...
Many countries have seen a dramatic increase in the reported incidence of cutaneous melanoma in rece...
Background and Objectives: Naevi may change in size, shape and colour due to multiple inherent and e...
Clinical guidelines recommend that people at high risk of melanoma receive regular surveillance, as ...
Introduction Melanoma is Australia's fourth most common cancer. Early detection is fundamental in ma...
The risk of hereditary cutaneous malignant melanoma was evaluated in 401 members of 14 families with...
INTRODUCTION: The evidence-based national clinical practice guidelines for the management of cutaneo...